Drug Enforcement D-166-2013

Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.

Status

Terminated

Classification

Class I

Report Date

February 27, 2013

Termination Date

August 9, 2016

Product Information

Product description
Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 blistered tablets per carton, Rx only; Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, Pkg by & Distributed by UDL Laboratories, Inc., Rockford, IL 61103; NDC 51079-254-21.
Product quantity
3,407 cartons
Reason for recall
Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide

Location & Firm

Recalling firm
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Address
1718 Northrock Ct, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-166-2013
Event ID
63899
Recall initiation date
December 14, 2012
Center classification date
February 15, 2013
Code info
Lot #: 3037841, 3040859, 3042573, Exp 12/13
More code info